PARIS & RADNOR, Pa. — Air Liquide (Euronext Paris:AI), world leader in gases, technologies and services for Industry and Health, and Airgas (NYSE:ARG), one of the leading suppliers of industrial gases and associated products and services in the U.S., today announced an agreement under which Air Liquide will acquire Airgas. Airgas shareholders will receive $143 […]
SAN DIEGO — ViaCyte, Inc., a privately-held regenerative medicine company with the first pluripotent stem cell-derived islet replacement therapy for the treatment of diabetes in clinical-stage development, today announced that the Company has entered into a non-exclusive licensing agreement with Takara Bio, Inc. Takara will utilize certain portions of ViaCyte’s cell differentiation technology to expand […]
LGC, the international life sciences and measurement company, today announces that it has acquired Maine Standards Company, the leading provider of calibration verification materials for clinical laboratories in the US. The acquisition bolsters LGC’s growing portfolio of reference materials and proficiency testing (PT) schemes for the clinical market. Euan O’Sullivan, Managing Director of LGC’s Standards […]
Applied Rigaku Technologies, Inc. (ART), a leading manufacturer of benchtop and process elemental analysis instrumentation, is proud to announce their association with Koehler Instrument Company Inc., a US-based manufacturer of testing instrumentation for the petroleum industry. ART and Koehler Instrument Co. recently signed a global distribution agreement whereby Koehler will distribute the Rigaku Benchtop Energy […]
CHALFONT ST. GILES, UK and AUSTIN, TX, USA – GE Healthcare’s Life Sciences business and Emerson Process Management, a global business of Emerson (NYSE: EMR), today announced a collaboration aimed at increasing productivity and improving efficiency in the production of biopharmaceuticals such as monoclonal antibodies and vaccines. The two companies will collaborate to integrate Emerson’s […]
MIAMI — Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer. The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering […]
Oxford, UK – Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology. This novel technology overcomes the limitations of restriction enzyme-based SNP probe approaches previously employed at BMGL for loss of heterozygosity […]
Craigavon, N.I., UK, –– Almac Diagnostics announced that it had entered into a collaboration with Illumina, Inc. (NASDAQ: ILMN) to establish a framework for the development of next-generation sequencing (NGS)-based companion diagnostic assays. The collaboration enables Almac to develop next-generation sequencing (NGS) assays using the Illumina MiSeqDx® instrument, the first FDA-cleared IVD NGS system designed […]
Genomics England has today announced that it has contracted with WuXi NextCODE as a Clinical Interpretation Partner for the 100,000 Genomes Project. The China, US and Iceland-based company is the first to work with them on cancer samples and will also interpret samples in rare disease. Genomics England will work with the clinical interpretation partners […]
CINCINNATI — Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced that it has made a minority investment in Oasis Diagnostics® Corporation (“Oasis”), with the right to acquire Oasis in the future. The terms of the transaction were not disclosed. Oasis designs, develops, manufactures and sells pre-analytic tools for the collection, preservation, and transportation of saliva/oral […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
